Krüger, P.; Schroll, M.; Fenzl, F.Q.; Hartinger, R.; Lederer, E.-M.; Görlach, A.; Gordon, L.B.; Cavalcante, P.; Iacomino, N.; Rathkolb, B.;
et al. Baricitinib and Lonafarnib Synergistically Target Progerin and Inflammation, Improving Lifespan and Health in Progeria Mice. Int. J. Mol. Sci. 2025, 26, 4849.
https://doi.org/10.3390/ijms26104849
AMA Style
Krüger P, Schroll M, Fenzl FQ, Hartinger R, Lederer E-M, Görlach A, Gordon LB, Cavalcante P, Iacomino N, Rathkolb B,
et al. Baricitinib and Lonafarnib Synergistically Target Progerin and Inflammation, Improving Lifespan and Health in Progeria Mice. International Journal of Molecular Sciences. 2025; 26(10):4849.
https://doi.org/10.3390/ijms26104849
Chicago/Turabian Style
Krüger, Peter, Moritz Schroll, Felix Quirin Fenzl, Ramona Hartinger, Eva-Maria Lederer, Agnes Görlach, Leslie B. Gordon, Paola Cavalcante, Nicola Iacomino, Birgit Rathkolb,
and et al. 2025. "Baricitinib and Lonafarnib Synergistically Target Progerin and Inflammation, Improving Lifespan and Health in Progeria Mice" International Journal of Molecular Sciences 26, no. 10: 4849.
https://doi.org/10.3390/ijms26104849
APA Style
Krüger, P., Schroll, M., Fenzl, F. Q., Hartinger, R., Lederer, E.-M., Görlach, A., Gordon, L. B., Cavalcante, P., Iacomino, N., Rathkolb, B., Pimentel, J. A. A., Östereicher, M., Spielmann, N., Wolf, C. M., de Angelis, M. H., & Djabali, K.
(2025). Baricitinib and Lonafarnib Synergistically Target Progerin and Inflammation, Improving Lifespan and Health in Progeria Mice. International Journal of Molecular Sciences, 26(10), 4849.
https://doi.org/10.3390/ijms26104849
